首页> 外文期刊>Cardiology research and practice >Agarwood Alcohol Extract Ameliorates Isoproterenol-Induced Myocardial Ischemia by Inhibiting Oxidation and Apoptosis
【24h】

Agarwood Alcohol Extract Ameliorates Isoproterenol-Induced Myocardial Ischemia by Inhibiting Oxidation and Apoptosis

机译:Agarwood酒精提取物通过抑制氧化和细胞凋亡来改善异丙酚诱导的心肌缺血

获取原文
           

摘要

Agarwood is a traditional medicine used for treating some diseases, including painful and ischemic diseases. This study was carried out to investigate the potential cardioprotective effect of the whole-tree agarwood-inducing technique-produced agarwood alcohol extract (WTAAE) on isoproterenol- (ISO-) induced myocardial ischemia (MI) in rats and explore the underlying molecular mechanisms. Compared to the MI group, WTAAE pretreatment significantly improved ST wave abnormal-elevation, mitigated myocardial histological damage; decreased creatinine kinase (CK), lactate dehydrogenase (LDH), alanine transaminase (ALT), and aspartate transaminase (AST) levels; reduced hydrogen peroxide (H2O2) and lipid peroxide (LPO) production; and increased total antioxidant capacity (T-AOC) and catalase (CAT) activities. Moreover, agarwood alcohol extracts (AAEs) markedly enhanced the mRNA levels of Nrf2-ARE pathway, and Bcl-2 reduced the apoptotic Bax family mRNA expressions. In addition, the effect of WTAAE was greater than that of wild agarwood alcohol extract (WAAE) and burning-chisel-drilling agarwood alcohol extract (FBAAE). All of these data indicate that WTAAE exerted the protective effects of MI, and its mechanism was associated with upregulating Nrf2-ARE and suppressing Bcl-2 pathways.
机译:琼脂是一种用于治疗某些疾病的传统医学,包括痛苦和缺血性疾病。进行了该研究,以研究全年伞形诱导技术产生的伞菌醇提取物(WTAAE)对大鼠诱导的异丙醇(ISO-)诱导的心肌缺血(MI)的潜在心脏保护作用,并探讨下面的分子机制。与MI组相比,WTAAE预处理显着改善ST波异常 - 升高,缓解心肌组织学损伤;减少肌酸酐激酶(CK),乳酸脱氢酶(LDH),丙氨酸转氨酶(ALT)和天冬氨酸转氨酶(AST)水平;减少过氧化氢(H 2 O 2)和脂质过氧化物(LPO)的生产;并增加总抗氧化能力(T-AOC)和过氧化酯酶(猫)活动。此外,Agarwood醇提取物(AAES)显着增强了NRF2的mRNA水平,并且Bcl-2减少了凋亡Bax家族mRNA表达。此外,WTAAE的效果大于野生伞状醇提取物(WAEAE)和燃烧 - 凿钻伞状醇提取物(FBAAE)。所有这些数据表明,WTAAE施加了MI的保护作用,其机制与上调NRF2和抑制Bcl-2途径有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号